Sales and Marketing

Showing 15 posts of 11524 posts found.

Roche’s Xeloda widens licence

April 1, 2010 Sales and Marketing Cancer, Roche, Xeloda, colorectal cancer

Roche’s oral chemotherapy drug Xeloda has been approved in Europe in combination with intravenous oxaliplatin for the treatment of patients …

Historic US reforms favour pharma – for now at least

April 1, 2010 Sales and Marketing Obama, US healthcare

The industry will be grateful for some certainty on the future market outlook and, overall, there is a strong belief …

Generic substitution will not deliver significant NHS savings, says EMIG

March 31, 2010 Sales and Marketing EMIG, NHS, generics

The Department of Health’s plans for automatic generic substitution will not result in significant savings for the NHS and should …

Boehringer enters the venture capital business

March 31, 2010 Research and Development, Sales and Marketing Boehringer, funding, venture capital

Boehringer Ingelheim is to tap into commercial opportunities in emerging technology by launching its own venture capital business. The Boehringer …

German price cuts denounced by industry

March 30, 2010 Sales and Marketing Germany, IQWIG

Pharma industry organisations have reacted angrily to new government plans in Germany which would enforce mandatory price reductions one year …

NICE changes its mind on Multaq

March 30, 2010 Sales and Marketing Multaq, NICE, Sanofi-Aventis

NICE has given preliminary approval of Sanofi-Aventis’ Multaq for the management of patients with atrial fibrillation. The decision reverses an …
Red Square

Russia debates pharma reform

March 30, 2010 Sales and Marketing Russia, em, emerging markets

The US is not the only country in the throes of passing significant legislation on major health issues.A bill has …

Lights go out for Earth Hour

March 29, 2010 Sales and Marketing charity, disaster

Over the weekend lights went out at heritage sites, modern marvels and royal palaces in honour of the World Wildlife …

SkyePharma filing Flutiform in Europe

March 26, 2010 Sales and Marketing Fluctiform, Skyepharma

SkyePharma is filing its asthma inhaler Flutiform with European regulatory authorities for approval. If approved Flutiform, a fluticasone and formoterol …
US healthcare reform

US health reform passes final vote

March 26, 2010 Sales and Marketing Obama, US healthcare

Controversial reforms to the US healthcare system have passed a final Congress vote after a series of Republican objections. The …
PMJonathanDancer

Jonathan Dancer joins PM Society

March 25, 2010 Medical Communications, Sales and Marketing Red Kite, appointment, medical communications, pm society, sales and marketing

The Pharmaceutical Marketing Society has appointed Jonathan Dancer to its committee. Jonathan is managing director of Red Kite Consulting Group, …
Glivec pack

NICE seeks compromise over Glivec approval

March 24, 2010 Sales and Marketing Glivec, NICE, Novartis

NICE says it is unlikely to approve the use of Glivec against gastrointestinal stromal tumours (GISTs) after surgery, but is …

GSK breathes more easily after Sandoz exit

March 24, 2010 Sales and Marketing Advair, Sandoz, generics, vectura

Sandoz has exited a deal to launch a generic rival to GSK’s top selling respiratory drug Advair. Sandoz, the generics …
QuintilesGeoffOwen

Quintiles hands Geoff Owen global business development role

March 24, 2010 Sales and Marketing Quintiles, appointment, sales and marketing

Contract services company Quintiles has appointed Geoff Owen to lead global business development for its Commercial group. As senior vice …

Virus contamination found in GSK’s Rotarix

March 23, 2010 Business Services, Manufacturing and Production, Sales and Marketing Contamination, GSK, Vaccine, manufacturing compliance

The European Medicines Agency has demanded more information “as a matter of urgency” from GlaxoSmithKline over a virus in its …
The Gateway to Local Adoption Series

Latest content